China, U.S. consumer protection MOU
This article was originally published in The Tan Sheet
Executive SummaryAs FDA and other agencies continue tests to determine whether bulk food and drug ingredients from China are contaminated, the Federal Trade Commission announces a memorandum of understanding with its Chinese counterpart to promote consumer protection cooperation. The non-binding MOU, which covers all products including drugs and dietary supplements, comes after FTC and China's State Administration for Industry and Commerce began work on consumer protection issues. "This is sort of a formal strengthening of the relationship that we agreed," says Jackie Dizdul, of FTC's Office of Public Affairs. FDA has ordered the detention without physical examination of all dentifrice products including aerosols, liquids, toothpastes and tooth powders with or without fluoride containing diethylene glycol after a sampling assignment discovered DEG in several Chinese products (1"The Tan Sheet" June 4, 2007, In Brief)
You may also be interested in...
The Committee on Energy and Commerce of the US House of Representatives has requested a set of documents from the FDA in order to assess whether the agency is doing enough to address the challenge of approving complex generics within its existing authorities, or whether additional authority is needed.
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.